Literature DB >> 6454385

Effects of sodium piperacillin on platelet function in normal volunteers.

L O Gentry, J G Jemsek, E A Natelson.   

Abstract

Piperacillin is a new semisynthetic penicillin which is similar in structure to carbenicillin and ticarcillin. Since the latter antibiotics have been shown to cause abnormalities in hemostasis, we studied the effects of piperacillin on blood coagulation and platelet function. Fifteen healthy volunteers received the drug in doses of either 100, 200, or 300 mg/kg per day for a period of 7 days. Serial studies showed no abnormalities in blood coagulation in any subject. Decreased platelet aggregation responses to adenosine diphosphate, epinephrine, collagen, and achidonic acid were commonly noted, but prolongation of the bleeding time occurred in only 3 of 15 subjects after 7 days of piperacillin administration. These results suggest that although piperacillin also induces platelet dysfunction, these effects may be less than those caused by ticarcillin or carbenicillin at an equivalent dosage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6454385      PMCID: PMC181471          DOI: 10.1128/AAC.19.4.532

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Study of the effects of ticarcillin on blood coagulation and platelet function.

Authors:  C H Brown; E A Natelson; M W Bradshaw; P Alfrey C; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  The hemostatic defect produced by carbenicillin.

Authors:  C H Brown; E A Natelson; W Bradshaw; T W Williams; C P Alfrey
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

3.  [Action of high doses of penicillin G on platelets. Study in Osler's disease].

Authors:  M J Lacombe; B Varet; P Godeau; G Herreman; A Cenac
Journal:  Nouv Presse Med       Date:  1974-06-01

4.  Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function.

Authors:  E A Natelson; W T Siebert; T W Williams; M W Bradshaw
Journal:  Am J Med Sci       Date:  1979 Nov-Dec       Impact factor: 2.378

5.  In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.

Authors:  P P Shah; D J Briedis; H G Robson; J P Conterato
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

6.  Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs.

Authors:  G J Johnson; G H Rao; J G White
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

7.  Defective platelet function following the administration of penicillin compounds.

Authors:  C H Brown; M J Bradshaw; E A Natelson; C P Alfrey; T W Williams
Journal:  Blood       Date:  1976-06       Impact factor: 22.113

  7 in total
  10 in total

1.  In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers.

Authors:  T A Tartaglione; R J Duma; G D Qureshi
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Toxic and adverse reactions encountered with new beta-lactam antibiotics.

Authors:  M F Parry
Journal:  Bull N Y Acad Med       Date:  1984-05

3.  Effects of apalcillin on platelet function in normal volunteers.

Authors:  L O Gentry; B A Wood; E A Natelson
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

4.  Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers.

Authors:  B Nunn; A Baird; P D Chamberlain
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

5.  Comparison of the effects of mezlocillin, carbenicillin, and placebo on normal hemostasis.

Authors:  J O Ballard; S G Barnes; F R Sattler
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 6.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

8.  Nafcillin-induced platelet dysfunction and bleeding.

Authors:  D P Alexander; M E Russo; D E Fohrman; G Rothstein
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 9.  Current guidelines on the use of antibacterial drugs in patients with malignancies.

Authors:  K H Mayer; O H DeTorres
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 10.  Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; D M Richards; R N Brogden; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.